Tumor Necrosis Factor-alpha Gene Promoter Region Polymorphism and the Risk of Coronary Heart Disease

Overview

Journal ScientificWorldJournal

Publisher Wiley

Specialty Biology

Date 2014 Jan 2

PMID 24381514

Citations 5

Authors

Gul Zareen Asifa

Afrose Liaquat

Iram Murtaza

Syed Ali Raza Kazmi

Qamar Javed

Affiliations

Soon will be listed here.

Abstract

Background: Tumor necrosis factor-alpha (TNF- α ) gene polymorphisms have been implicated in the manifestation of atherosclerosis. Controversy exists regarding the link between the cytokine's variant genotype and CHD among different ethnic groups. There have been fewer studies on the TNF- α gene -1031T>C and -863C>A polymorphisms in relation to CHD. Therefore, the current study was designed to investigate the association of the TNF- α gene -1031T>C and -863C>A polymorphisms with CHD in a Pakistani population.

Methods: Patients with CHD (n = 310) and healthy individuals (n = 310) were enrolled in this study. Genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).

Results: A significant difference was observed in the -863C>A polymorphism between patients with CHD and control subjects (P < 0.0001). CHD risk was positively associated with the variant allele -863A (P < 0.0001) in the study subjects. There was no significant link between the -1031T>C polymorphism and CHD risk in the study population. Haplotypes A-T and A-C of the TNF-alpha gene loci at -863 and -1031 showed higher frequency in the patient group compared with controls (P < 0.05).

Conclusion: The TNF- α -863C>A gene polymorphism was associated with the pathogenesis of CHD while the -1031T>C polymorphism did not show any link with the disease in a Pakistani population.

Citing Articles

Cytokine (IL-10, IL-6, TNF-α and TGF-β1) Gene Polymorphisms in Chronic Hepatitis C Virus Infection among Malay Male Drug Abusers.

Che Noh I, Ahmad I, Suraiya S, Musa N, Nurul A, Ruzilawati A Biomedicines. 2021; 9(9).

PMID: 34572300 PMC: 8469205. DOI: 10.3390/biomedicines9091115.

Association of tumor necrosis factor-α gene polymorphisms and coronary artery disease susceptibility: a systematic review and meta-analysis.

Huang R, Zhao S, Li Y, Liu F, Gong Y, Xing J BMC Med Genet. 2020; 21(1):29.

PMID: 32046680 PMC: 7014948. DOI: 10.1186/s12881-020-0952-2.

Gene polymorphism associated with TNF-α (G308A) IL-6 (C174G) and susceptibility to coronary atherosclerotic heart disease: A meta-analysis.

Yuepeng J, Zhao X, Zhao Y, Li L Medicine (Baltimore). 2019; 98(2):e13813.

PMID: 30633155 PMC: 6336626. DOI: 10.1097/MD.0000000000013813.

Tumor necrosis factor-alpha gene polymorphisms and susceptibility to ischemic heart disease: A systematic review and meta-analysis.

Zhang P, Wu X, Li G, He Q, Dai H, Ai C Medicine (Baltimore). 2017; 96(14):e6569.

PMID: 28383437 PMC: 5411221. DOI: 10.1097/MD.0000000000006569.

The role of gene variants of the inflammatory markers CRP and TNF-α in cardiovascular heart disease: systematic review and meta-analysis.

Hernandez-Diaz Y, Tovilla-Zarate C, Juarez-Rojop I, Banos-Gonzalez M, Torres-Hernandez M, Lopez-Narvaez M Int J Clin Exp Med. 2015; 8(8):11958-84.

PMID: 26550110 PMC: 4612795.

References

. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-63. DOI: 10.1016/S0140-6736(03)15268-3. View

Bayley J, Ottenhoff T, Verweij C . Is there a future for TNF promoter polymorphisms?. Genes Immun. 2004; 5(5):315-29. DOI: 10.1038/sj.gene.6364055. View

Baseggio L, Bartholin L, Chantome A, Charlot C, Rimokh R, Salles G . Allele-specific binding to the -308 single nucleotide polymorphism site in the tumour necrosis factor-alpha promoter. Eur J Immunogenet. 2004; 31(1):15-9. DOI: 10.1111/j.1365-2370.2004.00440.x. View

Skoog T, vant Hooft F, Kallin B, Jovinge S, Boquist S, Nilsson J . A common functional polymorphism (C-->A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet. 1999; 8(8):1443-9. DOI: 10.1093/hmg/8.8.1443. View

Mellick G . TNF gene polymorphism and quantitative traits related to cardiovascular disease: getting to the heart of the matter. Eur J Hum Genet. 2007; 15(6):609-11. DOI: 10.1038/sj.ejhg.5201816. View

Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H . Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens. 1998; 51(6):605-12. DOI: 10.1111/j.1399-0039.1998.tb03002.x. View

Elahi M, Asotra K, Matata B, Mastana S . Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim Biophys Acta. 2009; 1792(3):163-72. DOI: 10.1016/j.bbadis.2009.01.007. View

Sharma S, Sharma A, Kumar S, Sharma S, Ghosh B . Association of TNF haplotypes with asthma, serum IgE levels, and correlation with serum TNF-alpha levels. Am J Respir Cell Mol Biol. 2006; 35(4):488-95. DOI: 10.1165/rcmb.2006-0084OC. View

Goodwin B, Pendleton L, Levy M, Solomonson L, Eichler D . Tumor necrosis factor-alpha reduces argininosuccinate synthase expression and nitric oxide production in aortic endothelial cells. Am J Physiol Heart Circ Physiol. 2007; 293(2):H1115-21. DOI: 10.1152/ajpheart.01100.2006. View

10.

Udalova I, Richardson A, Denys A, Smith C, ACKERMAN H, Foxwell B . Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region. Mol Cell Biol. 2000; 20(24):9113-9. PMC: 102169. DOI: 10.1128/MCB.20.24.9113-9119.2000. View

11.

Nedwin G, Naylor S, Sakaguchi A, Smith D, Pennica D, Goeddel D . Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res. 1985; 13(17):6361-73. PMC: 321958. DOI: 10.1093/nar/13.17.6361. View

12.

Szekanecz Z . Pro-inflammatory cytokines in atherosclerosis. Isr Med Assoc J. 2008; 10(7):529-30. View

13.

Hajeer A, Hutchinson I . Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol. 2001; 62(11):1191-9. DOI: 10.1016/s0198-8859(01)00322-6. View

14.

Morange P, Tregouet D, Godefroy T, Saut N, Bickel C, Rupprecht H . Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study. J Mol Med (Berl). 2008; 86(10):1153-61. DOI: 10.1007/s00109-008-0375-6. View

15.

Kamoun M, Chelbi H, Houman M, Lacheb J, Hamzaoui K . Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease. Hum Immunol. 2007; 68(3):201-5. DOI: 10.1016/j.humimm.2006.12.006. View

16.

Skoog T, Hamsten A, Eriksson P . Allele-specific chromatin remodeling of the tumor necrosis factor-alpha promoter. Biochem Biophys Res Commun. 2006; 351(3):777-83. DOI: 10.1016/j.bbrc.2006.10.114. View

17.

Koch W, Tiroch K, von Beckerath N, Schomig A, Kastrati A . Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting. Cytokine. 2003; 24(4):161-71. DOI: 10.1016/j.cyto.2003.08.004. View

18.

Libby P, Ridker P, Hansson G . Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009; 54(23):2129-38. PMC: 2834169. DOI: 10.1016/j.jacc.2009.09.009. View

19.

Liang W, Lv M, Su X, Gao L, Fang W, Luo H . Association of tumor necrosis factor gene polymorphisms with susceptibility to dilated cardiomyopathy in a Han Chinese population. DNA Cell Biol. 2010; 29(10):625-8. DOI: 10.1089/dna.2010.1044. View

20.

Kampoli A, Tousoulis D, Antoniades C, Siasos G, Stefanadis C . Biomarkers of premature atherosclerosis. Trends Mol Med. 2009; 15(7):323-32. DOI: 10.1016/j.molmed.2009.06.001. View